ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NUVOW Holdco Nuvo Group DG Ltd

0.0333
0.00 (0.00%)
Jun 25 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 72
Bid Price 0.01
Ask Price 0.05
News -
Company Name Stock Ticker Symbol Market Type
Holdco Nuvo Group DG Ltd NUVOW NASDAQ Equity Warrant
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.0333 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.0333 0.0333
Trades Volume Avg Volume
1 72 -
Last Trade Time Type Quantity Stock Price Currency
10:54:44 72  0.0225 USD

Holdco Nuvo Group DG Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 1.11M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Holdco Nuvo Group DG

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NUVOW Message Board. Create One! See More Posts on NUVOW Message Board See More Message Board Posts

NUVOW Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Nuvo is leading a transformation in pregnancy care by providing clinicians and expectant mothers with access to medically-necessary remote pregnancy monitoring anytime, anywhere. Nuvo¿s INVU¿ platform is an FDA-cleared remote pregnancy monitoring and management system. It enables the delivery of remote non-stress tests (NSTs) and maternal and fetal heart rate monitoring, while pioneering new data-driven personalized pathways that can improve future health outcomes. INVU is being used by leading health providers and research institutions across the US and Israel. Nuvo will continue to expand the footprint of sales in the US and Israel and plans to introduce the product in Europe in 2024 following the hoped for granting of the CE mark in 2024 to provide remote access and insights not previously deemed possible.